{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:00:46Z","timestamp":1789876846116,"version":"4.0.1"},"reference-count":13,"publisher":"VM Media SP. zo.o VM Group SK","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologia i Neurochirurgia Polska"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pjnns.2017.10.015","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T16:35:30Z","timestamp":1510245330000},"page":"84-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Aripiprazole in treatment of Gilles de la Tourette syndrome \u2013 New therapeutic option"],"prefix":"10.5603","volume":"52","author":[{"given":"Piotr","family":"Janik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Szejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3595","reference":[{"key":"10.1016\/j.pjnns.2017.10.015_bib0070","doi-asserted-by":"crossref","DOI":"10.1089\/cap.2016.0026","article-title":"Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette's disorder in children and adolescents","author":"Sallee","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"10.1016\/j.pjnns.2017.10.015_bib0075","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.4088\/JCP.12m08189","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder","volume":"74","author":"Yoo","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.pjnns.2017.10.015_bib0080","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1176\/ajp.135.5.585","article-title":"A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome","volume":"135","author":"Ross","year":"1978","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.pjnns.2017.10.015_bib0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","article-title":"Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial","volume":"22","author":"Dion","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pjnns.2017.10.015_bib0090","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","article-title":"A placebo-controlled trial of risperidone in Tourette syndrome","volume":"60","author":"Scahill","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.pjnns.2017.10.015_bib0095","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","article-title":"Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study","volume":"39","author":"Sallee","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.pjnns.2017.10.015_bib0100","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":"Clonidine treatment of Gilles de la Tourette's syndrome","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pjnns.2017.10.015_bib0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.pjnns.2017.10.015_bib0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00002826-200211000-00009","article-title":"Neuropsychiatric effects of guanfacine in children with Tourette syndrome: a pilot study","volume":"25","author":"Cummings","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pjnns.2017.10.015_bib0115","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10578-013-0427-1","article-title":"Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial","volume":"45","author":"Ahmad","year":"2014","journal-title":"Child Psychiatry Hum Dev"},{"key":"10.1016\/j.pjnns.2017.10.015_bib0120","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/jama.2010.607","article-title":"Behavior therapy for children with Tourette disorder: a randomized controlled trial","volume":"303","author":"Piacentini","year":"2010","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.pjnns.2017.10.015_bib0125","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archgenpsychiatry.2011.1528","article-title":"Randomized trial of behavior therapy for adults with Tourette syndrome","volume":"69","author":"Wilhelm","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pjnns.2017.10.015_bib0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fnins.2016.00416","article-title":"Aripiprazole improves associated comorbid conditions in addition to tics in adult patients with Gilles de la Tourette syndrome","volume":"10","author":"Gerasch","year":"2016","journal-title":"Front Neurosci"}],"container-title":["Neurologia i Neurochirurgia Polska"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384317303079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028384317303079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T05:45:43Z","timestamp":1546926343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028384317303079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0028384317303079"],"URL":"https:\/\/doi.org\/10.1016\/j.pjnns.2017.10.015","relation":{},"ISSN":["0028-3843"],"issn-type":[{"value":"0028-3843","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aripiprazole in treatment of Gilles de la Tourette syndrome \u2013 New therapeutic option","name":"articletitle","label":"Article Title"},{"value":"Neurologia i Neurochirurgia Polska","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pjnns.2017.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}